AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience
Authors: Razzouk, BI Raimondi, SC Srivastava, DK Pritchard, M Behm, FG Tong, X Sandlund, JT Rubnitz, JE Pui, CH Ribeiro, RC
Citation: Bi. Razzouk et al., Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience, LEUKEMIA, 15(9), 2001, pp. 1326-1330
Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay
Authors: Chen, X Pan, Q Stow, P Behm, FG Goorha, R Pui, CH Neale, GAM
Citation: X. Chen et al., Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay, LEUKEMIA, 15(1), 2001, pp. 166-170
Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases
Authors: Krance, RA Hurwitz, CA Head, DR Raimondi, SC Behm, FG Crews, KR Srivastava, DK Mahmoud, H Roberts, WM Tong, X Blakley, RL Ribeiro, RC
Citation: Ra. Krance et al., Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases, J CL ONCOL, 19(11), 2001, pp. 2804-2811
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
Authors: Blanco, JG Dervieux, T Edick, MJ Mehta, PK Rubnitz, JE Shurtleff, S Raimondi, SC Behm, FG Pui, CH Relling, MV
Citation: Jg. Blanco et al., Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia, P NAS US, 98(18), 2001, pp. 10338-10343
Lactic acidosis: A metabolic complication of hematologic malignancies - Case report and review of the literature
Authors: Sillos, EM Shenep, JL Burghen, GA Pui, CH Behm, FG Sandlund, JT
Citation: Em. Sillos et al., Lactic acidosis: A metabolic complication of hematologic malignancies - Case report and review of the literature, CANCER, 92(9), 2001, pp. 2237-2246
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acutelymphoblastic leukemia cells
Authors: Srivannaboon, K Shanafelt, AB Todisco, E Porte, CP Behm, FG Raimondi, SC Pui, CH Campana, D
Citation: K. Srivannaboon et al., Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acutelymphoblastic leukemia cells, BLOOD, 97(3), 2001, pp. 752-758
Biology and outcome of childhood acute megakaryoblastic leukemia: a singleinstitution's experience
Authors: Athale, UH Razzouk, BI Raimondi, SC Tong, X Behm, FG Head, DR Srivastava, DK Rubnitz, JE Bowman, L Pui, CH Ribeiro, RC
Citation: Uh. Athale et al., Biology and outcome of childhood acute megakaryoblastic leukemia: a singleinstitution's experience, BLOOD, 97(12), 2001, pp. 3727-3732
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
Authors: Teitz, T Wei, T Valentine, MB Vanin, EF Grenet, J Valentine, VA Behm, FG Look, AT Lahti, JM Kidd, VJ
Citation: T. Teitz et al., Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN, NAT MED, 6(5), 2000, pp. 529-535
Acute lymphoblastic leukemia in a developing country: Preliminary results of a nonrandomized clinical trial in El Salvador
Authors: Bonilla, M Moreno, N Marina, N deReyes, G Shurtleff, SA Downing, JR Behm, FG Harrison, PL Ribeiro, RC Pena, O Crist, WM Antillon, FG
Citation: M. Bonilla et al., Acute lymphoblastic leukemia in a developing country: Preliminary results of a nonrandomized clinical trial in El Salvador, J PED H ONC, 22(6), 2000, pp. 495-501
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study
Authors: Harris, MB Shuster, JJ Pullen, J Borowitz, MJ Carroll, AJ Behm, FG Camitta, B Land, VJ
Citation: Mb. Harris et al., Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study, LEUKEMIA, 14(9), 2000, pp. 1570-1576
Prognostic factors in infants with acute myeloid leukemia
Authors: Pui, CH Raimondi, SC Srivastava, DK Tong, X Behm, FG Razzouk, B Rubnitz, JE Sandlund, JT Evans, WE Ribeiro, R
Citation: Ch. Pui et al., Prognostic factors in infants with acute myeloid leukemia, LEUKEMIA, 14(4), 2000, pp. 684-687
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies
Authors: Woo, MH Shuster, JJ Chen, C Bash, RO Behm, FG Camitta, B Felix, CA Kamen, BA Pui, CH Raimondi, SC Winick, NJ Amylon, MD Relling, MV
Citation: Mh. Woo et al., Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies, LEUKEMIA, 14(2), 2000, pp. 232-237
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital
Authors: Pui, CH Boyett, JM Rivera, GK Hancock, ML Sandlund, JT Ribeiro, RC Rubnitz, JE Behm, FG Raimondi, SC Gajjar, A Razzouk, B Campana, D Kun, LE Relling, MV Evans, WE
Citation: Ch. Pui et al., Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital, LEUKEMIA, 14(12), 2000, pp. 2286-2294
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- andlong-term effects
Authors: Arnaout, MK Radomski, KM Srivastava, DK Tong, X Belt, JR Raimondi, SC Behm, FG Santana, VM Crom, WR Mirro, J Ribeiro, RC
Citation: Mk. Arnaout et al., Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- andlong-term effects, LEUKEMIA, 14(10), 2000, pp. 1736-1742
T-ALL with monoclonal gammopathy and hairy cell features
Authors: Yetgin, S Olcay, L Yel, L Tuncer, M Tezcan, I Erdemli, E Oner, AF Behm, FG
Citation: S. Yetgin et al., T-ALL with monoclonal gammopathy and hairy cell features, AM J HEMAT, 65(2), 2000, pp. 166-170
Immunophenotyping of leukemia
Authors: Campana, D Behm, FG
Citation: D. Campana et Fg. Behm, Immunophenotyping of leukemia, J IMMUNOL M, 243(1-2), 2000, pp. 59-75
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2591-2596
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2691-2696
Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia
Authors: Wang, H Zheng, X Behm, FG Ratnam, M
Citation: H. Wang et al., Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia, BLOOD, 96(10), 2000, pp. 3529-3536
CD38 ligation inhibits normal and leukemic myelopoiesis
Authors: Todisco, E Suzuki, T Srivannaboon, K Coustan-Smith, E Raimondi, SC Behm, FG Kitanaka, A Campana, D
Citation: E. Todisco et al., CD38 ligation inhibits normal and leukemic myelopoiesis, BLOOD, 95(2), 2000, pp. 535-542
Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Neale, GAM Coustan-Smith, E Pan, Q Chen, X Gruhn, B Stow, P Behm, FG Pui, CH Campana, D
Citation: Gam. Neale et al., Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia, LEUKEMIA, 13(8), 1999, pp. 1221-1226
Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities
Authors: Mathew, S Behm, FG Dalton, J Raimondi, SC
Citation: S. Mathew et al., Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities, LEUKEMIA, 13(11), 1999, pp. 1713-1720
Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup
Authors: Rubnitz, JE Behm, FG Wichlan, D Ryan, C Sandlund, JT Ribeiro, RC Rivera, GK Hancock, ML Relling, MV Evans, WE Pui, CH Downing, JR
Citation: Je. Rubnitz et al., Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup, LEUKEMIA, 13(1), 1999, pp. 19-21
Sex differences in prognosis for children with acute lymphoblastic leukemia
Authors: Pui, CH Boyett, JM Relling, MV Harrison, PL Rivera, GK Behm, FG Sandlund, JT Ribeiro, RC Rubnitz, JE Gajjar, A Evans, WE
Citation: Ch. Pui et al., Sex differences in prognosis for children with acute lymphoblastic leukemia, J CL ONCOL, 17(3), 1999, pp. 818-824
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation
Authors: Rubnitz, JE Camitta, BM Mahmoud, H Raimondi, SC Carroll, AJ Borowitz, MJ Shuster, JJ Link, MP Pullen, DJ Downing, JR Behm, FG Pui, CH
Citation: Je. Rubnitz et al., Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation, J CL ONCOL, 17(1), 1999, pp. 191-196
Risultati: 1-25 | 26-31